Anke Rauterkus-Hennig

Amministratore Delegato presso RESAPHENE SUISSE AG

Health Technology

Finance

Profilo

Anke Rauterkus-Hennig is currently the Chairman & Chief Executive Officer of Resaphene Suisse AG and the Director of Bs Health Group AG since 2012.

Posizioni attive di Anke Rauterkus-Hennig

Società	Posizione	Inizio
RESAPHENE SUISSE AG	Amministratore Delegato	-
Bs Health Group AG Bs Health Group AG Investment ManagersFinance Bs Health Group AG operates as a Swiss venture capital company. The private company is based in Roggwil, Switzerland.	Direttore/Membro del Consiglio	01/01/2012

Tutte le posizioni attive di Anke Rauterkus-Hennig

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Anke Rauterkus-Hennig

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Resaphene Suisse AG Resaphene Suisse AG Medical SpecialtiesHealth Technology Resaphene Suisse AG operates as a medical technology company. It has been selling a tinnitus therapy device under the name tinniwell. The company was founded on 2015 and is headquartered in Roggwil, Switzerland.	Health Technology
Bs Health Group AG Bs Health Group AG Investment ManagersFinance Bs Health Group AG operates as a Swiss venture capital company. The private company is based in Roggwil, Switzerland.	Finance

Vedi le connessioni aziendali